Spinifex Appoints Declan Doogan as Non-Executive Chairman
Spinifex Pharmaceuticals announces the appointment of Dr Declan Doogan as Non-Executive Chairman. Dr Doogan brings to Spinifex more than 30 years’ experience of the global pharmaceuticals industry including more than 20 years with Pfizer.
Dr Doogan is currently Chief Medical Officer of Amarin Corporation and served as Interim Chief Executive Officer of the Company from 2009 to 2010. Prior to joining Amarin in 2007 as Head of R&D, Dr Doogan was Senior Vice President and Head of Worldwide Development at Pfizer Global Research & Development having held a number of senior positions in Pfizer in the US, the UK and Japan. Dr Doogan joined Pfizer in 1982, where he led the Zoloft® (sertraline HCl) clinical development program. He subsequently held a variety of senior positions within Pfizer and ultimately became head of the company’s development organization. Dr Doogan holds a number of non-executive directorships including Board Member of Sosei Corporation (Japan). Dr Doogan received his medical degree from Glasgow University in 1975. He is a Fellow of the Royal College of Physicians of Glasgow and the Faculty of Pharmaceutical Medicine in the UK.
Other news from the department people
